Merck spokeswoman: Sales layoffs to hit PA-based field reps

The job-cutting ax has come out for Merck's ($MRK) U.S. field force, as part of a move to cut 600 positions by August. Most at risk: Pennsylvania-based sales folks focused on declining primary care meds, a Merck spokeswoman tells FiercePharmaMarketing. Report